High Throughput News and Research

RSS
Developing and manufacturing custom recombinant antibodies for R&D

Developing and manufacturing custom recombinant antibodies for R&D

Cell Guidance Systems and Manchester BIOGEL collaborate to launch PODS-PeptiGels for 3D cell culture

Cell Guidance Systems and Manchester BIOGEL collaborate to launch PODS-PeptiGels for 3D cell culture

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

Study finds methylene blue is a low-micromolar inhibitor of the the SARS-CoV-2 spike protein and ACE2 interaction

The obstacles to developing high-throughput 3D wound healing models

The obstacles to developing high-throughput 3D wound healing models

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

Angiotensin-converting enzyme 2 allosteric binders found to be effective against SARS-CoV-2

The importance of the endosomal pathway for SARS-CoV-2 entry

The importance of the endosomal pathway for SARS-CoV-2 entry

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

In silico screening and testing of FDA approved drugs inhibiting SARS-CoV-2 spike protein cleavage

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Flow Eighteen38 receives €5 million EUR (c.$5.58 million USD) to expand production and biophysical capabilities

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

Development of RT-qPCR assays for differentiating SARS-CoV-2 Omicron BA.1 and BA.2 variants

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

Identification of compounds that inhibit SARS-CoV-2 Mac1-ADP-ribose binding

COVID-19 and the life sciences; what have we learned and where are we going?

COVID-19 and the life sciences; what have we learned and where are we going?

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

TGen and Deepcell collaborate to employ AI-based technology to classify and isolate diseased cells

TGen and Deepcell collaborate to employ AI-based technology to classify and isolate diseased cells

Researchers identify autoantibody targets in COVID-19 patients

Researchers identify autoantibody targets in COVID-19 patients

Novel, rapid and efficient assay for SARS-CoV-2 neutralizing antibodies

Novel, rapid and efficient assay for SARS-CoV-2 neutralizing antibodies

Mutational analysis of SARS-CoV-2 main protease

Mutational analysis of SARS-CoV-2 main protease

Ingenza collaborates with Johnson Matthey for efficient industrial enzyme synthesis

Ingenza collaborates with Johnson Matthey for efficient industrial enzyme synthesis

Streamlined, efficient approaches to cell culture spectrometry and analysis

Streamlined, efficient approaches to cell culture spectrometry and analysis

Can the COVID-19 delta variant evade vaccine-induced immunity?

Can the COVID-19 delta variant evade vaccine-induced immunity?